A Multi-Institutional Phase II Pilot Trial With Weekly Docetaxel and Herceptin as First or Second Line Therapy for HER2/Neu Overexpressing Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Docetaxel (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 09 Sep 2005 New trial record.